| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| olaparib for brca1 | 1.04 | 0.8 | 7572 | 9 | 18 |
| olaparib | 0.81 | 0.1 | 290 | 48 | 8 |
| for | 0.02 | 0.5 | 1448 | 24 | 3 |
| brca1 | 1.44 | 0.5 | 9583 | 11 | 5 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| olaparib for brca1 | 0.93 | 0.4 | 2608 | 76 |
| adjuvant olaparib for patients with brca1 | 1.2 | 0.4 | 5224 | 6 |
| olaparib breast cancer adjuvant | 1.51 | 1 | 9385 | 99 |
| olaparib for non brca ovarian cancer | 0.43 | 0.7 | 4426 | 6 |
| olaparib brca negative ovarian cancer | 0.84 | 0.4 | 4250 | 41 |
| adjuvant olaparib breast cancer fda | 1.32 | 1 | 6434 | 59 |
| olaparib breast cancer adjuvant nice | 0.57 | 0.1 | 7784 | 52 |
| indications for adjuvant olaparib | 0.09 | 0.6 | 96 | 18 |
| olaparib for breast cancer | 1.06 | 0.1 | 4376 | 53 |
| olaparib breast cancer nejm | 1.25 | 0.2 | 9272 | 2 |
| olaparib for metastatic breast cancer | 0.17 | 0.1 | 5294 | 44 |
| olaparib dose for breast cancer | 0.78 | 0.7 | 6612 | 90 |
| brca1 and 2 positive | 0.25 | 0.4 | 8369 | 56 |
| olaparib bevacizumab ovarian cancer | 0.72 | 0.9 | 3425 | 34 |
| olaparib breast cancer approval | 1.52 | 0.7 | 9827 | 76 |
| olaparib breast cancer uk | 1.26 | 0.5 | 660 | 31 |
